Vásová I - Search Results

1

[Subcutaneous chamber systems (ports) for long-term care in cancer patients].

Hájek R, Sevcík P, Ondrásek J, Mayer J, Vásová I, Král Z, Tomíska M, Krahulcová E, Penka M, Kubesová H, et al. Hájek R, et al. Among authors: vasova i. Vnitr Lek. 1995 Jan;41(1):21-7. Vnitr Lek. 1995. PMID: 7716888 Czech.

2

[Infections in patients with central venous systems for long-term venous access: pathogenesis, classification, diagnosis and therapy].

Hájek R, Burgetová D, Vásová I, Tomíska M. Hájek R, et al. Among authors: vasova i. Vnitr Lek. 1995 Jun;41(6):421-6. Vnitr Lek. 1995. PMID: 7676665 Review. Czech.

3

[Biological effects of allogenic leukocytes and leukocyte-depleted blood cell products].

Vásová I, Mayer J. Vásová I, et al. Vnitr Lek. 1995 Oct;41(10):713-8. Vnitr Lek. 1995. PMID: 8578706 Review. Czech.

4

[A new purine analog in the treatment of hematologic malignancy. I. Fludarabine].

Vásová I, Penka M, Hájek R, Mayer J, Krahulcová E. Vásová I, et al. Vnitr Lek. 1997 Jan;43(1):45-50. Vnitr Lek. 1997. PMID: 9221567 Review. Czech.

5

[Evaluation of the cardioprotective effect of bispiperazinedione ICRF-187 (Cardioxane) in patients treated with anthracyclines--an echocardiographic study].

Elbl L, Vásová I, Chaloupka V, Hájek R, Vorlícek J. Elbl L, et al. Among authors: vasova i. Vnitr Lek. 1996 Apr;42(4):268-73. Vnitr Lek. 1996. PMID: 8693714 Czech.

6

[Treatment of multiple myeloma--melphalan monotherapy after bone marrow transplantation].

Hájek R, Adam Z, Krejcí M, Vásová I, Král Z, Vorlícek J. Hájek R, et al. Among authors: vasova i. Vnitr Lek. 1996 Apr;42(4):278-84. Vnitr Lek. 1996. PMID: 8693716 Review. Czech.

7

[Treatment of multiple myeloma].

Hájek R, Vásová I, Adam Z, Krejcí M, Mayer J, Krahulová M. Hájek R, et al. Among authors: vasova i. Vnitr Lek. 1996 May;42(5):345-50. Vnitr Lek. 1996. PMID: 8768295 Review. Czech.

8

[Chemotherapy of resistant and recurrent lymphoma based on a combination of ifosfamide and etoposide. Antitumor effects, toxicity and stimulation of peripheral stem cells].

Mayer J, Korístek Z, Vásová I, Müllerová I, Král Z, Navrátil M, Klabusay M, Vorlícek J, Vodvárka P, Hejlová N, Penka M, Krahulcová E, Tomíska M, Adam Z, Hájek R. Mayer J, et al. Among authors: vasova i. Cas Lek Cesk. 1998 Oct 5;137(19):590-7. Cas Lek Cesk. 1998. PMID: 9818471 Clinical Trial. Czech.

9

[Warning signs preceding the development of septic shock in patients with neutropenia treated for hematologic malignancies].

Kubesová H, Penka M, Král Z, Vásová I, Hájek R, Adam Z, Navrátil M. Kubesová H, et al. Among authors: vasova i. Cas Lek Cesk. 1999 Mar 1;138(5):147-51. Cas Lek Cesk. 1999. PMID: 10376398 Czech.

10

[Cardiotoxicity of antineoplastic therapy].

Elbl L, Vásová I, Kiss I, Chaloupka V, Kubesová H, Vorlícek J. Elbl L, et al. Among authors: vasova i. Vnitr Lek. 2000 Mar;46(3):178-83. Vnitr Lek. 2000. PMID: 11048523 Review. Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters